Epsilon Healthcare Limited (ASX:EPN – Get Free Report) insider Zoe Hutchings acquired 307,934 shares of the business’s stock in a transaction dated Thursday, January 8th. The stock was acquired at an average cost of A$0.04 per share, with a total value of A$10,777.69.
Zoe Hutchings also recently made the following trade(s):
- On Tuesday, December 30th, Zoe Hutchings bought 519,426 shares of Epsilon Healthcare stock. The shares were acquired at an average cost of A$0.04 per share, for a total transaction of A$19,218.76.
Epsilon Healthcare Price Performance
The company has a market cap of $7.21 million, a price-to-earnings ratio of -0.54 and a beta of 0.92.
Epsilon Healthcare Company Profile
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Further Reading
- Five stocks we like better than Epsilon Healthcare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Epsilon Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Epsilon Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
